Detecting circulating microbial cell-free DNA by next-generation sequencing in patients with Mycobacterium avium complex-lung disease: A pilot study

Objectives: Determining a diagnosis for non-Tuberculous mycobacterium (NTM)-lung disease (LD) remains difficult. The value of circulating cell-free DNA (cfDNA) secreted from microbes has been established in the detection of pathogens in septic patients. However, it is unknown whether NTM-derived cfD...

Full description

Bibliographic Details
Main Authors: Yen-Han Tseng, Sheng-Wei Pan, Jia-Yih Feng, Wei-Juin Su, Chi-Ying F Huang, Yuh-Min Chen
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Tzu-Chi Medical Journal
Subjects:
Online Access:http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2024;volume=36;issue=1;spage=67;epage=75;aulast=
_version_ 1797299975840858112
author Yen-Han Tseng
Sheng-Wei Pan
Jia-Yih Feng
Wei-Juin Su
Chi-Ying F Huang
Yuh-Min Chen
author_facet Yen-Han Tseng
Sheng-Wei Pan
Jia-Yih Feng
Wei-Juin Su
Chi-Ying F Huang
Yuh-Min Chen
author_sort Yen-Han Tseng
collection DOAJ
description Objectives: Determining a diagnosis for non-Tuberculous mycobacterium (NTM)-lung disease (LD) remains difficult. The value of circulating cell-free DNA (cfDNA) secreted from microbes has been established in the detection of pathogens in septic patients. However, it is unknown whether NTM-derived cfDNA is detectable in plasma from patients with NTM-LD and whether this is associated with the disease status of NTM-LD, especially in patients with Mycobacterium avium complex (MAC)-LD. Materials and Methods: In this pilot study, from 2018 to 2019, we enrolled adult patients with MAC-LD at Taipei Veterans General Hospital in Taiwan for the detection of circulating cfDNA. We performed cfDNA extraction from plasma, next-generation sequencing (NGS) for nonhuman cfDNA, and sequence matching to a microbial database and then assessed the association between pathogen cfDNA and MAC-LD. Results: Two (40%) plasma samples from MAC-LD patients had detectable MAC-specific cfDNA, namely one instance of DNA polymerase III alpha subunit and one instance of ATP-binding cassette transporters permease. The plasma samples from the three other MAC-LD cases and the one tuberculosis control were negative for either NTM-derived cfDNA or tuberculosis-related cfDNA. In addition to MAC-specific cfDNA, Ralstonia solanacearum, Staphylococcus aureus, and Pasteurella multocida were the most observed bacteria in our patients. The two patients with MAC-cfDNA positivity yielded higher radiographic scores (P = 0.076) and presented a higher number of nonhuman reads than those without MAC-cfDNA positivity (P = 0.083). Conclusion: Using NGS method, we demonstrated MAC-cfDNA was detectable in patients with MAC-LD. Further large-scale research is warranted to assess the clinical value of detecting MAC-specific cfDNA in MAC-LD patients.
first_indexed 2024-03-07T22:59:28Z
format Article
id doaj.art-c265e7b6b38a41d5b1af520f43472bee
institution Directory Open Access Journal
issn 1016-3190
2223-8956
language English
last_indexed 2024-03-07T22:59:28Z
publishDate 2024-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Tzu-Chi Medical Journal
spelling doaj.art-c265e7b6b38a41d5b1af520f43472bee2024-02-22T15:29:06ZengWolters Kluwer Medknow PublicationsTzu-Chi Medical Journal1016-31902223-89562024-01-01361677510.4103/tcmj.tcmj_191_23Detecting circulating microbial cell-free DNA by next-generation sequencing in patients with Mycobacterium avium complex-lung disease: A pilot studyYen-Han TsengSheng-Wei PanJia-Yih FengWei-Juin SuChi-Ying F HuangYuh-Min ChenObjectives: Determining a diagnosis for non-Tuberculous mycobacterium (NTM)-lung disease (LD) remains difficult. The value of circulating cell-free DNA (cfDNA) secreted from microbes has been established in the detection of pathogens in septic patients. However, it is unknown whether NTM-derived cfDNA is detectable in plasma from patients with NTM-LD and whether this is associated with the disease status of NTM-LD, especially in patients with Mycobacterium avium complex (MAC)-LD. Materials and Methods: In this pilot study, from 2018 to 2019, we enrolled adult patients with MAC-LD at Taipei Veterans General Hospital in Taiwan for the detection of circulating cfDNA. We performed cfDNA extraction from plasma, next-generation sequencing (NGS) for nonhuman cfDNA, and sequence matching to a microbial database and then assessed the association between pathogen cfDNA and MAC-LD. Results: Two (40%) plasma samples from MAC-LD patients had detectable MAC-specific cfDNA, namely one instance of DNA polymerase III alpha subunit and one instance of ATP-binding cassette transporters permease. The plasma samples from the three other MAC-LD cases and the one tuberculosis control were negative for either NTM-derived cfDNA or tuberculosis-related cfDNA. In addition to MAC-specific cfDNA, Ralstonia solanacearum, Staphylococcus aureus, and Pasteurella multocida were the most observed bacteria in our patients. The two patients with MAC-cfDNA positivity yielded higher radiographic scores (P = 0.076) and presented a higher number of nonhuman reads than those without MAC-cfDNA positivity (P = 0.083). Conclusion: Using NGS method, we demonstrated MAC-cfDNA was detectable in patients with MAC-LD. Further large-scale research is warranted to assess the clinical value of detecting MAC-specific cfDNA in MAC-LD patients.http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2024;volume=36;issue=1;spage=67;epage=75;aulast=circulating cell-free dnamicrobial circulating cell-free dnamycobacterium avium complex-lung diseasenext-generation sequencing
spellingShingle Yen-Han Tseng
Sheng-Wei Pan
Jia-Yih Feng
Wei-Juin Su
Chi-Ying F Huang
Yuh-Min Chen
Detecting circulating microbial cell-free DNA by next-generation sequencing in patients with Mycobacterium avium complex-lung disease: A pilot study
Tzu-Chi Medical Journal
circulating cell-free dna
microbial circulating cell-free dna
mycobacterium avium complex-lung disease
next-generation sequencing
title Detecting circulating microbial cell-free DNA by next-generation sequencing in patients with Mycobacterium avium complex-lung disease: A pilot study
title_full Detecting circulating microbial cell-free DNA by next-generation sequencing in patients with Mycobacterium avium complex-lung disease: A pilot study
title_fullStr Detecting circulating microbial cell-free DNA by next-generation sequencing in patients with Mycobacterium avium complex-lung disease: A pilot study
title_full_unstemmed Detecting circulating microbial cell-free DNA by next-generation sequencing in patients with Mycobacterium avium complex-lung disease: A pilot study
title_short Detecting circulating microbial cell-free DNA by next-generation sequencing in patients with Mycobacterium avium complex-lung disease: A pilot study
title_sort detecting circulating microbial cell free dna by next generation sequencing in patients with mycobacterium avium complex lung disease a pilot study
topic circulating cell-free dna
microbial circulating cell-free dna
mycobacterium avium complex-lung disease
next-generation sequencing
url http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2024;volume=36;issue=1;spage=67;epage=75;aulast=
work_keys_str_mv AT yenhantseng detectingcirculatingmicrobialcellfreednabynextgenerationsequencinginpatientswithmycobacteriumaviumcomplexlungdiseaseapilotstudy
AT shengweipan detectingcirculatingmicrobialcellfreednabynextgenerationsequencinginpatientswithmycobacteriumaviumcomplexlungdiseaseapilotstudy
AT jiayihfeng detectingcirculatingmicrobialcellfreednabynextgenerationsequencinginpatientswithmycobacteriumaviumcomplexlungdiseaseapilotstudy
AT weijuinsu detectingcirculatingmicrobialcellfreednabynextgenerationsequencinginpatientswithmycobacteriumaviumcomplexlungdiseaseapilotstudy
AT chiyingfhuang detectingcirculatingmicrobialcellfreednabynextgenerationsequencinginpatientswithmycobacteriumaviumcomplexlungdiseaseapilotstudy
AT yuhminchen detectingcirculatingmicrobialcellfreednabynextgenerationsequencinginpatientswithmycobacteriumaviumcomplexlungdiseaseapilotstudy